146 related articles for article (PubMed ID: 21569199)
1. COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy.
Belshaw Z; Constantio-Casas F; Brearley MJ; Dunning MD; Holmes MA; Dobson JM
Vet Comp Oncol; 2011 Jun; 9(2):141-8. PubMed ID: 21569199
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2 in canine nasal carcinomas.
Impellizeri JA; Esplin DG
Vet J; 2008 Jun; 176(3):408-10. PubMed ID: 17517527
[TBL] [Abstract][Full Text] [Related]
3. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of hypofractionated radiotherapy for nasal tumours in 38 dogs (2005-2008).
Fujiwara A; Kobayashi T; Kazato Y; Yayoshi N; Fujita M
J Small Anim Pract; 2013 Feb; 54(2):80-6. PubMed ID: 23373834
[TBL] [Abstract][Full Text] [Related]
6. Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.
Knottenbelt C; Mellor D; Nixon C; Thompson H; Argyle DJ
J Small Anim Pract; 2006 Apr; 47(4):196-200. PubMed ID: 16573762
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of cyclooxygenase-2 in canine ovarian carcinomas.
Borzacchiello G; Russo V; Russo M
J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):247-9. PubMed ID: 17523957
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003).
Rassnick KM; Goldkamp CE; Erb HN; Scrivani PV; Njaa BL; Gieger TL; Turek MM; McNiel EA; Proulx DR; Chun R; Mauldin GE; Phillips BS; Kristal O
J Am Vet Med Assoc; 2006 Aug; 229(3):401-6. PubMed ID: 16881833
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas.
Borzacchiello G; Paciello O; Papparella S
J Comp Pathol; 2004 Jul; 131(1):70-6. PubMed ID: 15144801
[TBL] [Abstract][Full Text] [Related]
10. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 in canine epithelial nasal tumors.
Kleiter M; Malarkey DE; Ruslander DE; Thrall DE
Vet Radiol Ultrasound; 2004; 45(3):255-60. PubMed ID: 15200266
[TBL] [Abstract][Full Text] [Related]
12. Reirradiation of recurrent canine nasal tumors.
Bommarito DA; Kent MS; Selting KA; Henry CJ; Lattimer JC
Vet Radiol Ultrasound; 2011; 52(2):207-12. PubMed ID: 21388476
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of specific magnetic resonance imaging features in canine nasal tumours treated by radiotherapy.
Agthe P; Caine AR; Gear RN; Dobson JM; Richardson KJ; Herrtage ME
J Small Anim Pract; 2009 Dec; 50(12):641-8. PubMed ID: 19954440
[TBL] [Abstract][Full Text] [Related]
14. Comparison of epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) immunohistochemical expression and outcomes in canine nasal carcinomas treated with radiation therapy.
Fu DR; Kadosawa T
J Vet Med Sci; 2022 Sep; 84(9):1237-1243. PubMed ID: 35851267
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of eight cats with non-lymphoproliferative nasal tumours treated by megavoltage radiotherapy.
Mellanby RJ; Herrtage ME; Dobson JM
J Feline Med Surg; 2002 Jun; 4(2):77-81. PubMed ID: 12027506
[TBL] [Abstract][Full Text] [Related]
16. Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in canine nasal carcinomas.
Paciello O; Borzacchiello G; Varricchio E; Papparella S
J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):406-10. PubMed ID: 17877580
[TBL] [Abstract][Full Text] [Related]
17. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
18. Palliation of clinical signs in 48 dogs with nasal carcinomas treated with coarse-fraction radiation therapy.
Gieger T; Rassnick K; Siegel S; Proulx D; Bergman P; Anderson C; LaDue T; Smith A; Northrup N; Roberts R
J Am Anim Hosp Assoc; 2008; 44(3):116-23. PubMed ID: 18451069
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis and treatment for 98 patients with carcinoma of nasal cavity].
Hu WH; Xie FY; Chen DZ; Wu Y; Jiao JJ; Peng WJ; Yan C; Fang SH
Ai Zheng; 2004 Nov; 23(11 Suppl):1542-5. PubMed ID: 15566676
[TBL] [Abstract][Full Text] [Related]
20. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs.
Théon AP; Madewell BR; Harb MF; Dungworth DL
J Am Vet Med Assoc; 1993 May; 202(9):1469-75. PubMed ID: 8496103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
